Evaluation of FluoroType MTB for direct detection of Mycobacterium tuberculosis complex and GenoType MTBDRplus for determining rifampicin and isoniazid resistance
In recent years, several molecular methods have been introduced for diagnosis of Mycobacterium tuberculosis complex (MTBC), and detecting the drug resistance in clinical specimens. The FluoroType MTB (FT MTB) assay uses real-time polymerase chain reaction (PCR) to detect MTBC in clinical specimens....
Main Authors: | Gonca Erkose Genc, Dilek Satana, Esra Yildirim, Zayre Erturan, Yildiz Yegenoglu, Meltem Uzun |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-07-01
|
Series: | Biotechnology & Biotechnological Equipment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13102818.2018.1466662 |
Similar Items
-
Descripción de las mutaciones de Mycobacterium tuberculosis que confieren resistencia a rifampicina e isoniacida detectadas mediante GenoType® MTBDRplus V.2 en Colombia
by: Claudia Llerena, et al.
Published: (2017-01-01) -
Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles
by: Kalaiselvi Kumarasingam, et al.
Published: (2018-01-01) -
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin
by: Mahamadou Bassirou Souleymane, et al.
Published: (2023-08-01) -
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
by: Chiara Tersigni, et al.
Published: (2021-10-01) -
Selenium as a therapeutic adjuvant for isoniazid/rifampicin-induced hepatotoxicity
by: Elias Adikwu, et al.
Published: (2020-01-01)